CVE-2025-32731A reflected cross-site scripting (xss) vulnerability exists in the radiationDoseReport.php functionality of meddream MedDream PACS Premium 7.3.5.860.
Updated under an hour ago ()
Does this affect you?
It affects MedDream PACS Premium and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.75%, higher than 54% of scored CVEs.
Do this next
Free account, 1 product
A reflected cross-site scripting (xss) vulnerability exists in the radiationDoseReport.php functionality of meddream MedDream PACS Premium 7.3.5.860. A specially crafted malicious url can lead to arbitrary javascript code execution. An attacker can provide a crafted URL to trigger this vulnerability.
- CVSS
- 6.1 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
- Weakness (CWE)
- CWE-79
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.75% (percentile 54)
- Assigned by
- talos
- NVD analysis
- Modified
- Record last updated
- Nov 3, 2025
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
MedDream MedDream PACS Premium meddream:pacs_premium (from the name) | 7.3.5.860 | CNA record |
meddream pacs_server meddream:pacs_server | 7.3.5.860 | NVD |
References
- https://talosintelligence.com/vulnerability_reports/TALOS-2025-2176exploit, third-party-advisory
- https://www.talosintelligence.com/vulnerability_reports/TALOS-2025-2176
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.